Antibodies

Lung Cancer Antibodies

Lung

Lung cancers are the third most diagnosed cancer in the United States, with about 13.5% of new cancer cases classified as lung, contributing 27.2% of cancer deaths yearly. As of 2011, there were approximately 402,000 people living with lung cancer in the United States. Those diagnosed with lung cancer have a 5 year survival rates of only 16.8%. Over the last 10 years, the rate of new lung cancer cases has fallen 1.5% per year, while the death rate has fallen 1.8% per year. Biocare Medical is proud to offer key lung antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Lung and Bronchus Cancer. National Cancer Institute. Bethesda, MD,http://seer.cancer.gov/statfacts/html/lungb.html

Desmoglein 3 + Napsin A

$373.00 Select options

TTF-1 + CK5

$408.00 Select options

p63 + TRIM29

$520.00 Select options

p40 (M)

$187.00$771.00 Select options

Folate Receptor alpha IHC Assay Kit

$467.00$700.00 Select options

Cytokeratin 7 (CK7)

$126.00$477.00 Select options

CD56

$158.00$670.00 Select options

Surfactant apoprotein-A [32E12]

$154.00$894.00 Select options

Calretinin

$145.00$638.00 Select options

Gall Bladder & Pancreatic Cancer Antibodies

Gall Bladder & Pancreatic Cancer Antibodies

Pancreatic cancers are a rare diagnosed cancer in the United States, with about 2.8% of new cancer cases classified as pancreatic, contributing approx.. 6.8% of cancer deaths yearly. As of 2011, there were approximately 44,000 people living with pancreatic cancer in the United States. Those diagnosed with pancreatic cancer have a 5 year survival rate of 6.7%. Over the last 10 years, the rate of new cancer cases has been stable while the death rate has risen 0.4% each year. Biocare Medical is proud to offer key pancreatic and gall bladder antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Pancreas Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/pancreas.html

β-catenin

$90.00$320.00 Select options

CD10

$105.00$662.00 Select options

Chromogranin A

$109.00$443.00 Select options

Cytokeratin 7

$125.00$516.00 Select options

Cytokeratin 19

$116.00$470.00 Select options

E-cadherin

$109.00$550.00 Select options

Glypican 3

$136.00$529.00 Select options

Mucin 5AC

$150.00 Select options

S100P

$122.00$490.00 Select options

Breast Cancer Antibodies

Breast Cancer Antibodies

Breast cancers are the second most diagnosed cancer in the United States, with about 14% of new cancer cases classified as breast and contributing 6.9% of cancer deaths yearly. As of 2011, there were approximately 2,900,000 women living with breast cancer in the United States. Those diagnosed with breast cancer have a 5 year survival rate of 89.2%. Over the last 10 years, the new breast cancer case rate has been stable, while the death rate has dropped 1.9% per year. Biocare Medical is proud to offer key breast antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Breast Cancer. National Cancer Institute. Bethesda, MD,http://seer.cancer.gov/statfacts/html/breast.html

CK5/14 + p63 + CK7/18

$597.00$1,881.00 Select options

GCDFP-15 + Mammaglobin

$375.00 Select options

p120 + E-cadherin

$432.00 Select options

Estrogen Receptor (ER) [SP1]

$151.00$915.00 Select options

Progesterone Receptor (PR) [16]

$116.00$583.00 Select options

GATA-3

$139.00$595.00 Select options

Cytokeratin 7 (CK7)

$126.00$477.00 Select options

Calponin

$139.00$612.00 Select options

c-erbB-2/HER2

$145.00$455.00 Select options

Cervical Cancer Antibodies

Cervical Cancer Antibodies

Cervical cancers are a relatively rare diagnosed cancer in the United States, with about 0.7% of new cancer cases classified as cervical, contributingapprox. 0.7% of cancer deaths yearly. As of 2011, there were approximately 250,000 women living with cervical cancer in the United States. Those diagnosed with cervical cancer have a 5 year survival rate of 67.9%. Over the last 10 years, both the new cancer case rate and the death rate have dropped 1.2% and 1.3% per year, respectively. Biocare Medical is proud to offer key cervical antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Cervix Uteri Cancer. National Cancer Institute. Bethesda, MD,http://seer.cancer.gov/statfacts/html/cervix.html

HPV-16 (CAMVIR-1)

$498.00 Select options

HPV Cocktail Broad Spectrum

$326.00$734.00 Select options

CA 125

$134.00$649.00 Select options

CEA (M)

$100.00$363.00 Select options

CEA (P)

$57.00$440.00 Select options

p63

$219.00$21,136.00 Select options

CD117/c-kit

$171.00$477.00 Select options

Topoisomerase II alpha

$117.00$292.00 Select options

VEGF

$129.00$314.00 Select options

Head & Neck Cancer Antibodies

Head & Neck Cancer Antibodies

Head and neck cancers are rare diagnosed cancers in the United States, with about 2.5% of all new cancer cases classified as oral cavity and pharynx, contributingapprox. 1.4% of cancer deaths yearly. As of 2011, there were approximately 282,000 people living with head and neck cancers in the United States. Those diagnosed with head and neck cancers have a 5 year survival rate of 62.7%. Over the last 10 years, both the new cancer case rate and the death rate have been stable. Biocare Medical is proud to offer key pancreatic and gall bladder antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Oral Cavity and Pharynx Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/oralcav.html

Androgen Receptor

$173.00$494.00 Select options

Calponin

$139.00$612.00 Select options

CD117/c-kit

$171.00$477.00 Select options

Cytokeratin 7 (CK7)

$126.00$477.00 Select options

DOG1

$102.00$386.00 Select options

GFAP

$84.00$386.00 Select options

HPV-16

$498.00 Select options

p63

$219.00$21,136.00 Select options

SOX10 (M)

$125.00$420.00 Select options

Ovarian Cancer Antibodies

Ovarian Cancer

Ovarian cancers are a relatively rare diagnosed cancer in the United States, with about 1.3% of new cancer cases classified as ovarian yet contributing 2.4% of cancer deaths yearly. As of 2011, there were approximately 189,000 women living with ovarian cancer in the United States. Those diagnosed with ovarian cancer have a 5 year survival rate of 44.6%. Over the last 10 years, both the new cancer case rate and the death rate have dropped 1.1% and 2.0% per year, respectively. Biocare Medical is proud to offer key ovarian antibodies that may aid in the identification of their respective proteins by IHC in FFPE tissues.

SEER Cancer Statistics Factsheets: Ovary Cancer. National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/statfacts/html/ovary.html

PAX8

$122.00$601.00 Select options

CDH17

$137.00$399.00 Select options

CDX2 + CK7

$502.00$1,552.00 Select options

CD99

$102.00$360.00 Select options

CD99

$134.00$649.00 Select options

CK7

$126.00$477.00 Select options

CDX2

$213.00$1,210.00 Select options

Human Chorionic Gonadotropin (Beta)

$75.00$185.00 Select options

Inhibin, Alpha

$154.00$668.00 Select options